228 related articles for article (PubMed ID: 20102300)
1. Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.
Hedegaard A; Ripa RS; Johansen JS; Jørgensen E; Kastrup J
Scand J Clin Lab Invest; 2010 Apr; 70(2):80-6. PubMed ID: 20102300
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.
Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G;
Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135
[TBL] [Abstract][Full Text] [Related]
3. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
4. Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial.
Overgaard M; Ripa RS; Wang Y; Jørgensen E; Kastrup J
Int J Cardiol; 2010 Apr; 140(3):351-5. PubMed ID: 19131132
[TBL] [Abstract][Full Text] [Related]
5. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
[TBL] [Abstract][Full Text] [Related]
6. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
[TBL] [Abstract][Full Text] [Related]
7. Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty.
Misztal M; Stopyra K; Gackowski A; Zmudka K; Piwowarska W
Cardiol J; 2009; 16(5):440-6. PubMed ID: 19753523
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
[TBL] [Abstract][Full Text] [Related]
9. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).
Dohi T; Maehara A; Brener SJ; Généreux P; Gershlick AH; Mehran R; Gibson CM; Mintz GS; Stone GW
Am J Cardiol; 2015 Mar; 115(5):563-70. PubMed ID: 25586335
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of YKL-40 increases in patients with acute myocardial infarction.
Nøjgaard C; Høst NB; Christensen IJ; Poulsen SH; Egstrup K; Price PA; Johansen JS
Coron Artery Dis; 2008 Jun; 19(4):257-63. PubMed ID: 18480670
[TBL] [Abstract][Full Text] [Related]
11. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
12. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
14. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
[TBL] [Abstract][Full Text] [Related]
15. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI.
Cetin M; Kocaman SA; Canga A; Kırbaş A; Yılmaz A; Erdoğan T; Akgül O; Uğurlu Y; Durakoğlugil ME
Herz; 2013 Mar; 38(2):202-9. PubMed ID: 22955689
[TBL] [Abstract][Full Text] [Related]
17. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease.
Wang Y; Ripa RS; Johansen JS; Gabrielsen A; Steinbruchel DA; Friis T; Bindslev L; Haack-Sørensen M; Jørgensen E; Kastrup J
Scand Cardiovasc J; 2008 Oct; 42(5):295-302. PubMed ID: 18615353
[TBL] [Abstract][Full Text] [Related]
18. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
Pei Q; Sang WF; Zhao XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.
Orozović V; Rafajlovski S; Gligić B; Miailović Z; Obradović S; Ratković N; Djenić N; Baskot B
Prilozi; 2007 Jul; 28(1):23-38. PubMed ID: 17921916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
